Navigation Links
11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
Date:11/24/2008

uciary duties to their shareholders, as opposed to spending time and shareholder money to further entrench themselves and the executive management team as the Company appears to plunge forward on a path to self-destruction."

In addition to Mr. E. Anthony Woods, who in addition to serving as Chairman of LCA-Vision, also serves as a Director of Cincinnati Financial Corporation and as a Director of Anchor Funding Services, the letter dated November 24, 2008, was also copied to Mr. William Bahl, who serves as Chairman of LCAV's Compensation Committee, Director and Chairman of the Nominating Committee of the Board of Cincinnati Financial Corporation and as President & Co-Founder of Bahl & Gaynor; Mr. John Gutfreund, who serves as Chairman of LCAV's Nominating and Governance Committee and on the Board of Directors of several over-the-counter traded companies, including GVI Securities Solutions; John Hassan, Chairman of LCAV's Audit Committee; and Steven Straus, LCAV's CEO.

(The full text of the letter appears below.)

About Dr. Stephen N. Joffe

Stephen N. Joffe, MD, FACS, age 65, is the founder and former Chairman and Chief Executive Officer of LCA-Vision. He was the founder of LCA-Vision's corporate predecessor, Laser Centers of America, Inc., and served as its Chairman of the Board and Chief Executive Officer from its formation in 1985 until its merger into LCA-Vision in 1995. In 1983, Stephen Joffe also founded and served as Chairman of Surgical Laser Technologies, Inc. until 1989. He is presently the Chief Executive Officer of the Hearing Foundation, Inc., a hearing company, and Co-Founder of Joffe MediCenter LLC, a healthcare services company. In addition Dr. Joffe is an Esteemed Quondum Professor of Surgery at the University of Cincinnati Medical Center, an honor he has held since 1990. He has held other medical faculty appointments at the Universities of London, Glasgo
'/>"/>

SOURCE Steve Joffe
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
2. Senator Norm Coleman Praised for Leading Successful Effort to Derail $11.4 Million Minnesota Medicare Cuts
3. Barr Shareholders Approve Pending Teva Acquisition
4. Cord Blood America Posts Letter to Shareholders: New Administrations Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders
5. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
6. MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares
7. Westaim terminates reorganization agreement and cancels shareholders meeting
8. GeneThera - CHANGING DIRECTIONS - an Update to Shareholders
9. Luoxin Announces 2008 Third Quarterly Results; Profit Attributable to Shareholders Surged 62.9% to Approximately RMB 138,141,000
10. Z Trim Holdings, Inc. Releases Letter to Shareholders
11. MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... (PRWEB) , ... July 30, ... ... released a video, “Beachside Nursing Center,” to announce its position as one ... ratings. Beachside's administrator and staff members support the CMS rating system, which ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax ... New Tool That Increases Training Capability , World renown body weight trainer, ... ( http://www.Zejax.com ), that dramatically increases a person’s training capability. , The American ...
(Date:7/30/2015)... ... 2015 , ... Boston Web Marketing is proud ... Partners is the platform for search marketing agencies to communicate with the Google ... to run successful search marketing campaigns. Google Partners also affords businesses the opportunity ...
(Date:7/30/2015)... ... July 30, 2015 , ... Gummy smile surgeon, Dr. Alex ... and surgery, as well as the patented gum depigmentation treatmet. Dr. Farnoosh is a ... with many patients from around the world. , “Like treatment of any other disease ...
(Date:7/30/2015)... ... , ... InventHelp, a leading inventor service company, announces that one ... it easy to apply lotion or medication to a hard-to-reach area. This invention is ... or medication to the back, and provides thorough coverage. The product would prevent the ...
Breaking Medicine News(10 mins):Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... ... ... ... ...
... When stroke strikes, choking off blood supply to the brain, ... a stroke is left untreated, making it a race to ... Forty-five percent of Americans 135 million people -- are ... facilities that are best equipped to care for them if ...
... Mission ... bolstering the fund’s ability to invest in promising bioscience companies emerging from the University ... ... partner to its first venture fund, bolstering the fund’s ability to invest in promising ...
... , ... Agency, FlexRN, Unveils New Corporate Branding & Website , ... Stafford, VA (PRWeb) February 23, 2010 -- FlexRN, ... of its new corporate branding and the launch of its new website at ...
... children, report says , WEDNESDAY, Feb. 24 (HealthDay News) ... uninsured children with asthma by 75 percent by enrolling ... programs and expanding eligibility, a new report suggests. , ... for kids with asthma costs an average of 50 ...
... ... ... ... ...
Cached Medicine News:Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 2Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 3Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 4Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 5Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 6Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 7Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 8Health News:US Oncology Announces Expanded Educational Resources to Cancer Patients Through New Affiliations with CURE & NexCura 9Health News:Half of Americans live more than an hour away from lifesaving stroke care 2Health News:Half of Americans live more than an hour away from lifesaving stroke care 3Health News:QB3 Adds Zcube As Limited Partner In Mission Bay Capital Fund 2Health News:QB3 Adds Zcube As Limited Partner In Mission Bay Capital Fund 3Health News:QB3 Adds Zcube As Limited Partner In Mission Bay Capital Fund 4Health News:Nurse Staffing Agency, FlexRN, Unveils New Corporate Branding & Website 2Health News:Existing Health Programs Could Help More Kids With Asthma 2Health News:Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel 2Health News:Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel 3Health News:Manduka Turns up the Heat With Introduction of eQua(TM) Hot Yoga Towel 4
(Date:7/30/2015)... 30, 2015 Takeda Pharmaceutical Company Limited ... fulfill the post-marketing commitment and submissions of data ... Multi-Database Bladder Cancer Risk Characterization Study , a ... conducted in four European countries, for pioglitazone containing ... 10 years of follow-up. Findings demonstrate that there ...
(Date:7/30/2015)... SAN FRANCISCO , July 30, 2015 ... devices market is expected to reach USD 23.01 ... Grand View Research, Inc. Growing base of geriatric population, ... and infections, and rising level of awareness among target ... impact rendering drivers over the forecast period. According to ...
(Date:7/30/2015)... What can be expected from ... going to grow at the fastest rates? Visiongain ... 2025, assessing data, trends, opportunities and prospects there. ... charts, and graphs. Discover the most lucrative areas in ... study lets you assess forecasted sales at overall world ...
Breaking Medicine Technology:Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
Medicine Products: